| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |